AEMD — Aethlon Medical Share News
0.000.00%
Last trade - 00:00Brief: Aethlon Medical Announces Financial Results For Fourth Quarter 2025
Aethlon Medical Inc expected to post a loss of $1.01 a share - Earnings Preview
Aethlon Medical Inc reports results for the quarter ended December 31 - Earnings Summary
Aethlon Medical Inc expected to post a loss of 21 cents a share - Earnings Preview
Brief: Aethlon Advances Hemopurifier® Study In Solid Tumors Not Responding To Anti-PD-1 Antibodies
Brief: Aethlon Medical Granted 180-Day Extension To Regain Nasdaq Compliance
Aethlon Medical Inc reports results for the quarter ended September 30 - Earnings Summary
Aethlon Medical Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Aethlon Medical Reaches Key Milestone With Enrollment Of The First Patient In (FPI) Its Hemopurifier Cancer Trial In Australia
Brief: Aethlon Medical Says James B. Frakes To Serve As Co’S Permanent Chief Executive Officer
Aethlon Medical Inc reports results for the quarter ended in June - Earnings Summary
Aethlon Medical Inc expected to post a loss of 31 cents a share - Earnings Preview
Brief: Aethlon Medical Receives Second Ethics Committee Approval For Hemopurifier® Cancer Trial
Aethlon Medical Inc expected to post a loss of 31 cents a share - Earnings Preview
Aethlon Medical Inc reports results for the quarter ended in March - Earnings Summary
Brief: Aethlon Medical Announces Financial Results For The Fiscal Year Ended March 31, 2024 And Provides Corporate Update
Brief: Aethlon Medical- Co Received Multiple Inquiries Regarding Current, Multi-State Outbreak Of H5n1 Avian Influenza (H5n1 Hpai) Virus In Dairy Cattle
Aethlon Medical Inc expected to post a loss of $1.23 a share - Earnings Preview
Brief: Aethlon Medical Receives Ethics Committee Approval For Hemopurifier® Cancer Trial